Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 6-K Current report (foreign)
- 99.1 Notice and Proxy Statement with Respect to the Company's Special Meeting of Shareholders
- 99.2 Proxy for Holders of Ordinary Shares with Respect to the Company's Special Meeting of Shareholders
- 99.3 Voting Instruction Card for American Depositary Share Holders with Respect to the Company's Special Meeting of Shareholders
CANF similar filings
- 13 Apr 20 Can Fite Received Approval for COVID-19 Clinical Trial in Israel, Patient Enrollment and Dosing to Commence Immediately
- 7 Apr 20 Can-Fite Reports Positive Top Line Results from its Phase II NASH Study with Namodenoson
- 2 Apr 20 Notice of Special Meeting of Shareholders
- 1 Apr 20 Notice of Special Meeting of Shareholders
- 30 Mar 20 Can-Fite Implements Interim Analysis for its Phase III Psoriasis Trial with Data Expected Q4 2020
- 27 Mar 20 Can-Fite Reports 2019 Financial Results & Provides Clinical Development Update
- 23 Mar 20 Report of Foreign Private Issuer
Filing view
External links
